Predictor variable | Patients never started cART* | Patients on cARTā | ||
---|---|---|---|---|
Ā | HR [95% CI] | Pvalue | HR [95% CI] | Pvalue |
Gender | Ā | Ā | Ā | Ā |
āāāFemale | 1 | Ā | 1 | Ā |
āāāMale | 0.73 [0.36-1.47] | 0.38 (NS) | 1.49 [0.84- 2.62] | 0.17 (NS) |
Median age, years | Ā | Ā | Ā | Ā |
āāāā¤38 | 1 | Ā | 1 | Ā |
āāā>38 | 0.86 [0.47-1.58] | 0.62 (NS) | 1.42 0.89 2.27 | 0.14 (NS) |
Region of origin | Ā | Ā | Ā | Ā |
āāāGermany | 1 | Ā | 1 | Ā |
āāāSub-Saharan Africa | 4.05 [1.87-8.78] | <0.001 | 5.15 [2.76-9.60] | <0.001 |
āāāOther countries | 1.75 [0.81-38.1] | 0.16 | 2.22 [1.18-4.20] | 0.014 |
HIV-transmission risk group | Ā | Ā | Ā | Ā |
āāāOthersā | 1 | Ā | 1 | Ā |
āāāMSM | 0.68 [0.31-1.51] | 0.34 | 0.60 [0.32-1.10] | 0.10 (NS) |
CD4+ cell count (cells/Ī¼l) | Ā | Ā | Ā | Ā |
āāāā„200 | 1 | Ā | 1 | Ā |
āāā<200 | 8.22 [4.36-15.51] | <0.001 | 1.90 [1.14-3.15] | 0.013 |
Viral load (log10 copies/ml) | Ā | Ā | Ā | Ā |
āāā< 5 | 1 | Ā | 1 | Ā |
āāāā„ 5 | 2.51 [1.33-4.75] | 0.005 | 1.77 [1.11-2.82] | 0.016 |